Edluar sublingual tablets (dissolve under the tongue) are used for the short treatment of insomnia where individuals are finding it difficult to fall asleep when they first go to bed.
Dosage adjustment may be necessary when Edluar is combined with other CNS-depressant drugs because of the potentially additive effects [see Warnings and Precautions (5.1)]. 2.4 Administration The effect of Edluar may be slowed by ingestion with or immediately after a meal. Edluar sublingual tabl...
Twitter Google Share on Facebook zolpidem (redirected fromEdluar) Medical zol·pi·dem (zōl′pə-dĕm′) n. A non-benzodiazepine sleep-inducing drug, C19H21N3O, used in its tartrate form to treat insomnia. [(a)zol(e) + p(yrim)id(ine) + alteration ofam(ide).] ...
摘要: Orexo 公司宣传美国食品和药物管理局已经批准了Edluar作为一种舌下含服片剂治疗失眠症,该片剂具有5mg和10mg两种规格。去年,Orexo公司的合作 伙伴Meda公司已经获得了把该药推向全球市场的许可证,并且它们期望在2009年下半年把产品推向美国市场。Orexo将会从Meda公司获得相关税...
Orexo公司新药Edluar被FDA批准用于治疗失眠症
上传人:csfrc·上传时间:2009-12-23 1/1
Studies have shown that Edluar has a faster sleep-induction effect, whereas it did not differ from the oral formulation in terms of sleep maintenance or side effects. This review also discusses the mechanism of action of zolpidem and its pharmacokinetic profile in comparison to Edluar. Efficacy ...
申请类型 NDA 申请号 021997 药品名称 EDLUAR 活性成分 ZOLPIDEM TARTRATE 活性成分中文 暂无权限 执行时间 2018-10-26 持有公司 MYLAN SPECIALITY LP 说明书 下载 VIP试用医疗器械查询APP下载客服中心常见问题数据可视化数据分析挖掘系统网站地图业务介绍友情链接 400-678-0778 投诉热线: (023) ...
商标名 EDLUAR 申请人 MYLAN SPECIALITY LP 剂型 TABLET 给药途径 SUBLINGUAL 剂量 10MG 申请类型 N NDA 21997 查看FDA药品专利信息 产品号 2 TE代码 AB 批准日 2009/03/13 RLD标识 Yes 类型 Yes 申请人全称 RX 查看物化性质 术语解释: A/ANDA:Abbreviated New Drug Application, 仿制药上市申请 Discn:被终止...
Zolpidem (Ambien, Ambien CR, Zolpimist, Edluar, [Tovalt ODT has been discontinued]) is a sedative medication prescribed for the treatment of insomnia. Side effects, drug interactions, warnings and precautions, and pregnancy and breastfeeding safety information should be reviewed prior to taking an...